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BACKGROUND: Previous studies showed an increased risk of thyroid cancer among children and adolescents exposed to radioactive
iodines released after the Chornobyl (Chernobyl) accident, but the effects of screening, iodine deficiency, age at exposure and
other factors on the dose–response are poorly understood.
METHODS: We screened 11 970 individuals in Belarus aged 18 years or younger at the time of the accident who had estimated
131I thyroid doses based on individual thyroid activity measurements and dosimetric data from questionnaires. The excess odds ratio
per gray (EOR/Gy) was modelled using linear and linear–exponential functions.
RESULTS: For thyroid doseso5Gy, the dose–response was linear (n¼ 85; EOR/Gy¼ 2.15, 95% confidence interval: 0.81–5.47), but
at higher doses the excess risk fell. The EOR/Gy was significantly increased among those with prior or screening-detected diffuse
goiter, and larger for men than women, and for persons exposed before age 5 than those exposed between 5 and 18 years, although
not statistically significant. A somewhat higher EOR/Gy was estimated for validated pre-screening cases.
CONCLUSION: 10–15 years after the Chornobyl accident, thyroid cancer risk was significantly increased among individuals exposed to
fallout as children or adolescents, but the risk appeared to be lower than in other Chornobyl studies and studies
of childhood external irradiation.
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Convincing evidence exists of an association between exposure to
external radiation and an increased risk of thyroid cancer
(Ron and Schneider, 2006), but risks from internally deposited
radioactive iodines were not well studied until recently. The
Chornobyl (Chernobyl) nuclear power plant accident resulted in
exposure of populations in Ukraine, Belarus and the Russian
Federation to large amounts of radionuclides (chiefly 131I, 133I and
137Cs) (UNSCEAR, 2000). Those exposed as children or adolescents
received comparatively high radiation doses due to the small size
of thyroid gland and high consumption of milk contaminated with
radioactive iodines (Gavrilin et al, 2004).
An increase in thyroid cancer among exposed children and
adolescents in the contaminated areas has been reported since the
accident (Kazakov et al, 1992; Astakhova et al, 1998; Jacob et al,
1999). Questions, however, have been raised about the potential
effects of screening and case ascertainment as well as modifying
effects of iodine deficiency on risk estimates (Boice, 2005).
The modifying effects of gender, age at exposure, and time since
exposure (Ron, 2007) and their differences and similarities with
the risks observed after external irradiation (Shore, 1992; Ron and
Schneider, 2006) are not well understood.
We initiated two screening studies of children and adolescents
exposed to Chornobyl fallout in Ukraine and Belarus using similar
designs to clarify these unresolved issues (Stezhko et al, 2004).
In the Ukrainian study, we estimated an excess odds ratio per gray
(EOR/Gy) of 5.25 (95% confidence intervals (CIs): 1.70–27.5) for
prevalent thyroid cancer detected during initial screening (Tronko
et al, 2006). In this report, we evaluated the dose–response for
prevalent thyroid cancers diagnosed during the first round
of screening in Belarus. We also present an analysis of validated
self-reported pre-screening cases.
MATERIALS AND METHODS
A detailed description of the study population and methods has
been published previously (Stezhko et al, 2004). We identified
38 543 individuals aged 18 years or younger at the time of the
Chornobyl accident on 26 April 1986 who had thyroid radioactivity
measurements taken in Belarus within 2 months after the accident.
We attempted to trace these individuals through local and regional
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address bureaus, military registration offices, departments of
education and public health, and medical establishments.
Approximately 5% (n¼ 1804) of the potential study subjects were
ineligible (incorrect age, died, incarcerated, moved out of the
country, etc.) and 20 526 (53.3%) could not be traced. Of the 16 213
individuals who were traced and invited to participate in the
study, 11 970 (73.8%) were screened for thyroid diseases (11 903 in
1996–2001 and 67 in 2002–2004). During screening, 202
individuals were determined to be ineligible due to incorrect age
(n¼ 114), incorrect identification (n¼ 20), or lack of thyroid tissue
due to primary thyroid gland aplasia (n¼ 10) or surgery for benign
thyroid condition (n¼ 58). An additional 104 subjects were
excluded because their doses could not be estimated adequately.
For the main analyses, we also excluded the 53 subjects who had a
prior thyroid cancer, leaving a total of 11 611 subjects.
The study was approved by institutional review boards in
Belarus and the United States. Informed consent was provided by
the study participants or by accompanying guardians for minors.
The majority of study subjects resided in Minsk and Gomel
oblasts (an oblast is an administrative subdivision similar in size to
a state or province) and were screened at study centres in Minsk
and Gomel cities or at local medical clinics by visiting mobile
screening teams. The initial protocol called for biennial screening,
but by decree of the Ministry of Health of Belarus,
all persons under the age of 18 years at the time of screening
(almost a third of the cohort) were recalled annually for screening
examinations. Thyroid screening consisted of ultrasound exam-
ination and palpation by a sonographer and a clinical examination
with independent palpation by an endocrinologist. Any discre-
pancies were resolved by a third examination conducted jointly by
both doctors. At the time of screening, participants were
administered questionnaires to ascertain demographic, residential,
dietary and medical history, and blood and spot urine samples
were collected.
Patients with thyroid nodules detected either on palpation or
ultrasonogram that measured at least 10mm and all nodules
that measured 5–10mm and were sonographically suspicious for
malignancy (hypoechogenic, indistinct border, calcified inclusions,
extension through the thyroid capsule or suspicious lymphadeno-
pathy) or with diffusely abnormal thyroid tissue accompanied by
unexplained cervical lymphadenopathy were referred to the Minsk
and Gomel study centres for further evaluation and ultrasound-
guided fine needle aspiration (FNA) biopsy.
Thyroid cancers were included in the analysis if they were
surgically removed within 3 years of initial screening. Two study
pathologists diagnosed thyroid cancers based on examination of
tumour tissue. All diagnoses were confirmed by the Chornobyl
Tissue Bank (CTB) or an ad hoc international panel of thyroid
pathologists. Pre-screening thyroid cancers were defined as cases
diagnosed after the accident and reported by subjects at initial
screening. Cancers were validated by review of patients’ medical
and pathology records.
131I represents about 95% of the thyroid dose (Minenko et al,
2006), and thyroid doses mainly came from intake of
131I-contaminated milk. Thyroid doses, estimated using methodo-
logy similar to that used in the Ukrainian study (Likhtarev et al,
2006), were based on: (1) direct thyroid measurements; (2) a
radioecological model, which was used to assess the temporal
variation of 131I in the thyroid and (3) personal interviews, which
provided information on individual dietary and lifestyle habits that
were used to adjust the radioecological model. The results of direct
thyroid measurements in Belarus were corrected for contribution
to the measured signal from external surface contamination
of body and clothes as well as internal contamination of cohort
member’s body with caesium isotopes. Additional data sources
were used to update the parameters of the dosimetry model,
including thyroid volume measurements from the Sasakawa
Memorial Foundation to derive age-specific thyroid masses
(Skryabin et al, 2010); measurements of 131I in soil to verify the
validity of calculated 131I deposition density in each settlement;
and 131I measurements in soil and grass samples to derive
an interception factor of 131I by vegetation.
Statistical methods
We analysed the prevalence of thyroid cancer using models for the
binomial odds (Breslow and Day, 1987). The dose categories were
selected to evenly distribute cases. We fitted an EOR model
to continuous doses to estimate the EOR/Gy where the disease
odds is:
expða xÞð1þ b d expðg zÞÞ ð1Þ
where d represents radiation dose, x and z are covariate vectors
representing confounding and effect modification variables,
respectively, and a, b and g are unknown parameters.
Past iodine deficiency was evaluated using proxy indicators,
including place of residence at the time of the accident, self-
reported history of diffuse goiter, diffuse goiter diagnosed during
screening and enlarged thyroid (thyroid volume418ml for
women and425ml for men) (Rasmussen et al, 2002). In addition,
we evaluated gender, age at the time of the accident, and oblast of
residence, urban/rural status and age at screening, history of
nodular goiter, and urinary iodine concentration as risk factors
and/or possible modifiers of the dose–response. We retained
potential confounding variables in the model if they significantly
improved the model fit or if the estimate of the EOR changed
by more than 10%.
We analysed data using the EPICURE software package (Preston
et al, 1993). All statistical tests were two-sided with a specified type
I error of 0.05, and 95% CIs were estimated by maximum
likelihood procedures. Linear trend test was based on the means of
the dose categories.
RESULTS
Analysis of prevalent cases detected during screening
Of the 595 subjects referred for FNA at the first screening cycle, the
referral was cancelled for 18 subjects (3.0%) who did not meet the
FNA criteria and FNA was performed for 553 subjects for a
compliance rate of 95.8%. Of the 167 subjects referred for surgery,
152 complied (91.0%). Additional three surgeries were performed
outside the study, but their pathology slides were reviewed by the
study pathologists. All but one of the 87 thyroid cancers were
papillary carcinomas (1 was follicular carcinoma). Nine cases
had two or more separate thyroid cancers in different locations
and thirteen cases had simultaneous diagnoses of thyroid cancer
and follicular adenoma. Of the 87 cases, 5 were discovered during
surgery for benign thyroid conditions.
Adjusting for radiation dose, background thyroid cancer ORs
were non-significantly higher for women compared to men
(OR¼ 1.40, P¼ 0.12) and older ages at screening (P¼ 0.19;
Table 1). The prevalence rate was significantly higher for
individuals with a self-reported history of nodular (OR¼ 23.21,
Po0.001) or diffuse goiter (OR¼ 5.15, Po0.001), or with nodular
and diffuse goiter diagnosed at screening (ORs¼ 19.79 and 3.16,
Po0.001). Subjects with a family history of nodular goiter had an
increased OR (OR¼ 3.54, Po0.001). Oblast of residence at the
time of screening, urban/rural status and current urinary iodine
concentration levels were not associated with thyroid cancer after
adjustment for radiation dose. Gender, age at screening and
oblast of residence at the time of screening were independent risk
factors of the background thyroid cancer risks and were retained
in all further models.
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Thyroid doses among the 11 611 subjects ranged from nearly
0 to 32.80Gy (Figure 1) with an arithmetic mean of 0.56 (s.d.¼ 1.18),
and differed significantly between cases and non-cases (1.08 vs
0.56Gy, Po0.001). Increasing thyroid doses were significantly
associated with increased risk of thyroid cancer (Plinear trendo0.001,
not shown). When the highest category was split at 5 Gy to reflect
a changing dose–response pattern, the linear trend remained
highly significant (Plinear trendo0.01; Table 2). A linear model
did not fit the data over the full range of doses and the test
of no departure from linearity was rejected (P¼ 0.05). A linear–
exponential model provided an improved fit to the data
(Figure 2; estimates b¼ 3.11 and g¼0.15 for an OR at 1Gy
of 3.68).
For doses o5Gy (omitting 118 non-cases, 2 cases), linearity
was not rejected (P¼ 0.90) and the estimated EOR/Gy was 2.15
(95% CI: 0.81–5.47, Po0.001). Further restriction to subjects with
doses o1Gy (omitting an additional 23 cases, 1534 non-cases)
resulted in a linear dose–response with an EOR/Gy of 4.92 (95%
CI: 1.32–17.12). We limited remaining analyses to subjects with
doses o5Gy. We observed non-significantly higher dose–
response estimates for men (P¼ 0.08; Table 3). Age at exposure
did not significantly modify the radiation dose and thyroid cancer
association (P¼ 0.48), although risk estimates decreased with
increasing age. There was a suggestion of increased dose effects for
subjects residing in Gomel oblast at the time of the accident
(P¼ 0.07). The EOR/Gy was larger in subjects with history of
Table 1 Descriptive characteristics of prevalent thyroid cases and non-cases
Cases Non-cases
Variable Value N % N % Odds ratioa 95% CI P-valueb
Gender Men 37 42.53 5602 48.61 1 0.12
Women 50 57.47 5922 51.40 1.40 0.91–2.15
Age at screening, years 10–14 13 14.90 1379 12.00 1 0.19
15–17 14 16.10 2161 18.80 0.89 0.41–1.91
18–20 12 13.80 2010 17.40 1.03 0.46–2.32
21–23 8 9.20 1891 16.40 0.71 0.29–1.75
24–26 19 21.80 1840 16.00 1.75 0.83–3.67
27–29 15 17.20 1533 13.30 1.73 0.79–3.79
30–34 6 6.90 708 6.10 1.61 0.59–4.43
History of nodular goiter No 55 63.20 11 297 98.00 1 o0.001
Yes 32 36.80 227 2.00 23.21 14.34–37.57
History of diffuse goiter No 78 89.70 11 277 97.90 1 o0.001
Yes 9 10.30 247 2.10 5.15 2.49–10.67
Nodular goiter diagnosed during screening No 39 44.83 10 895 94.54 1 o0.001
Yes 48 55.17 629 5.46 19.79 12.65–30.96
Diffuse goiter diagnosed during screening No 54 62.07 9750 84.61 1 o0.001
Yes 33 37.93 1774 15.39 3.16 2.02–4.94
Family history of nodular goiter No 67 77.01 10 649 92.40 1 o0.001
Yes 20 22.99 875 7.60 3.54 2.13–5.89
Oblast of residence at screening Minsk 16 18.40 3147 27.30 1 0.54
Gomel 61 70.10 7110 61.70 1.12 0.63–2.01
Other 10 3.50 1267 11.40 1.29 0.58–2.87
Urban status Urban 39 44.83 7007 60.80 1
Rural 48 55.17 4517 39.20 1.44 0.91–2.29 0.12
Urinary iodine concentration, mg l1 0–19 10 11.50 1266 11.00 0.79 0.38–1.63 0.47
20–49 19 21.80 2988 25.90 0.65 0.37–1.17
50–99 30 34.50 3236 28.10 1
100–299 25 28.70 3426 29.70 0.83 0.49–1.43
300+ 3 3.40 455 3.90 0.75 0.23–2.48
Unknown 0 0.00 153 1.30
Abbreviation: CI¼ confidence interval. aModel adjusted for thyroid dose, age at risk, gender and oblast of residence (Minsk, Gomel, Other). bP-value from the likelihood ratio test
evaluating statistical significance of adding corresponding variables to the model.
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Figure 1 Distribution of thyroid doses in the cohort
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diffuse goiter or diagnosed with diffuse goiter or enlarged thyroid
volume at screening compared with those without these conditions
(Po0.01). Dose effects were unrelated to current urinary iodine
concentration (P¼ 0.30). Tumours ranged in size from 1 to 47mm
(mean¼ 11mm, median¼ 9mm). The estimated dose effects did
not differ by tumour size (EOR/Gy¼ 1.35 and 3.40 for 5–10 and
X10mm, respectively, P¼ 0.30; Table 3).
Analysis of pre-screening cases
Self-reported diagnosis of pre-screening thyroid cancer was
confirmed for 53 subjects. The majority of the pre-screening
thyroid cancers were diagnosed among men (54.7 vs 42.5%), and
among persons exposed at a younger age (mean age 5.5 years vs
8.7) and with a higher mean dose (mean dose 1.77 vs 1.08 Gy).
They were more likely to live in rural areas, both at the time of the
accident and at the time of screening (not shown). Both pre-
screening and screening-detected cases had a similar family
history of nodular goiter (17.0 and 23.0%), but different self-
reported history of diffuse goiter (0 and 10.3%). Similar to the
analysis of screening-detected cases, the linear–exponential model
provided the best fit to the data on pre-screening cases (estimates
b¼ 12.87 and g¼0.12 for an OR at 1Gy of 12.41; not shown).
Exclusion of 118 non-cases and 5 pre-screening thyroid cancer
cases with doses 5Gy and above resulted in the linear EOR/Gy of
8.18 (95% CI: 2.11–72.71), Po0.001 and the exponential term was
no longer significant (P¼ 0.43; Table 4). There was no significant
effect modification by gender (P¼ 0.88), age at exposure (P¼ 0.32)
or place of residence at the time of the accident (P¼ 0.15).
Combined analysis of pre-screening and screening cases
When we combined pre-screening cases with cases diagnosed
during regular screening, the EOR/Gy estimate from the linear
model based on doses o5Gy was 3.16 (95% CI: 1.49–6.95,
Po0.001; Table 4). The linear slope did not differ significantly
between the pre-screening and screening cases (P¼ 0.58; not
shown). Although there was no significant difference in radiation
effects according to gender and age at exposure in the combined
cases, the EOR/Gy for those living in Gomel oblast in 1986 was four
times the value for those from other oblasts (EOR/Gy¼ 3.93 and
1.00 respectively, P¼ 0.04).
DISCUSSION
Our results from the first screening in the cohort of Belarusian
children and adolescents exposed to radioactive iodine fallout
from the Chornobyl accident showed a significant dose–response
relationship between 131I thyroid dose and thyroid cancer, which
was linear–exponential across the full range of doses, but
consistent with linearity below 5Gy (EOR/Gy¼ 2.15, 95% CI:
0.81–5.47). There was some indication that men and those
exposed at younger ages had larger radiation-associated risks, as
measured by EOR/Gy, but they were not statistically significant.
Proxy indicators of iodine deficiency enhanced radiation-asso-
ciated risks of thyroid cancer. Similar effects with higher-point
EOR/Gy estimates were observed for pre-screening thyroid cancer
cases confirmed through medical records.
A major strength of the study was the individual estimates of 131I
thyroid doses based on thyroid radioactivity measurements
performed within 2 months after the accident and on question-
naire data collected during screening and before diagnosis. Thus,
although based on the prevalence data and cross-sectional by
design, our study results were not affected by selection or recall
bias. All subjects were screened using a standard protocol and
screeners were masked to estimates of radiation dose, thus
diminishing potential confounding effects of screening and
Table 2 Odds ratios and 95% CI by thyroid dose category
Dose category,
Gy
Mean dose,
Gy
Cases
(N¼87) %
Non-cases
(N¼11 524) %
Odds
ratioa,b 95% CI
0–0.049 0.02 6 6.9 1985 17.2 1
0.05–0.14 0.09 11 12.6 2554 22.2 1.42 0.51–3.98
0.15–0.29 0.22 13 14.9 2053 17.8 2.09 0.76–5.75
0.30–0.44 0.37 10 11.5 1281 11.1 2.59 0.90–7.47
0.45–0.64 0.54 10 11.5 1034 9.0 3.27 1.13–9.46
0.65–1.24 0.90 16 18.4 1421 12.3 3.95 1.46–10.69
1.25–2.24 1.64 10 11.5 686 6.0 5.27 1.80–15.46
2.25–4.99 3.18 9 10.3 392 3.4 8.70 2.85–26.55
5.00–32.80 8.84 2 2.3 118 1.0 6.75 1.26–36.22
Abbreviations: CI¼ confidence interval; Gy¼ gray. aModel adjusted for age at risk, gender and oblast of residence (Minsk, Gomel, Other). bP-value of the test of linear trend
based on mean values for dose categories¼o0.01.
0
2
4
6
8
10
12
14
0 2 4 6 8
Mean dose (Gy)
O
dd
s 
ra
tio
 e
st
im
at
es
Linear 0–32 Gy
Linear–exponential 0–32 Gy
Categorical (9 cat) 0–32 Gy
Linear below 5 Gy
Figure 2 Categorical odds ratios and fitted dose–response lines
Risk of post-Chornobyl thyroid cancer in Belarus
LB Zablotska et al
184
British Journal of Cancer (2011) 104(1), 181 – 187 & 2011 Cancer Research UK
E
p
id
e
m
io
lo
g
y
dose-related differential screening. Our findings were further
strengthened by the high FNA and surgery compliance rates
(95.8% and 91.0%, respectively) and the review of all cases by
international pathology experts. Our estimate of EOR was robust
and not affected by exclusion of one follicular carcinoma case,
cases with simultaneous follicular adenoma or cases with
incidental finding of cancer from analysis (EOR/Gy of 2.15, 2.74
and 2.55, respectively).
The study has several limitations. Because only 11 970 of the
36 739 individuals eligible to participate (32.6%) were screened, a
possible non-participation bias is a concern. The major reason for
non-participation was the difficulty in locating and tracing eligible
subjects. Thus, slightly more than 50% of potential subjects could
not be traced, primarily because of the high mobility of this young
population in the period between the 1986 Chornobyl accident and
the start of screening in 1997, and the limited identifying
information in the thyroid activity logs through which eligibility
was determined. Among those invited into the study, 73.8%
participated, which is similar to other large cohort studies (Szklo,
1998) and to the participation rate observed in the parallel study in
Ukraine (67.5%) (Tronko et al, 2006). About a quarter of those
invited to participate did not come for screening, primarily
because they lived far from screening centres. Although mobile
teams were organised to screen study subjects who lived in areas
distant from the stationary screening centres in Minsk or Gomel,
this was not possible for areas in other oblasts with sparse
distribution of potential study subjects. These areas were also less
contaminated after the accident, which could potentially explain
the significant differences in dose distribution among participants
and non-participants (43% participated among those with thyroid
activity measurements 1Gy and above vs 31% with measurements
of 0.3–1.0 Gy and 26% of those with measurement o0.3Gy)
(Stezhko et al, 2004). However, since screening procedures were
uniformly applied to all subjects, any differences in participation
were non-differential and would not bias the EOR/Gy estimates for
prevalent cases detected during screening. The dose-dependent
participation of self-reported pre-screening cases cannot be
excluded and could have resulted in higher EOR/Gy estimates.
Furthermore, all statistical analyses were adjusted for effects of
other potential risk factors such as age, gender and oblast of
residence (proxy for iodine deficiency) to eliminate possible effects
of differential selection. The annual screening for individuals less
than 18 years of age compared to biennial for those more than 18
years may have resulted in increased diagnosis of thyroid cancers
among the former. The difference in risk estimates between the
two age groups was sizeable although not statistically significant
(EOR/Gy of 5.10 for those screened before age 18 years and 1.62 for
older study participants, P¼ 0.30), but is probably due to higher
risks among those exposed at younger ages. Only the central dose
estimates were available at the time of analysis and uncertainties in
dosimetry have not been taken into account, but their potential
impact on the thyroid risk estimates will be evaluated in a later
publication.
A recently published parallel study in Ukraine (Tronko et al,
2006) observed a higher mean thyroid dose (0.78 vs 0.56 Gy).
In both studies those younger at the time of exposure tended to
have higher risks per unit of dose, whereas the effects of gender
were in opposite directions. The estimate of risk among those
with doses less than 5Gy in Ukraine (EOR/Gy¼ 7.35, 95% CI:
2.23–53.11) was much closer in magnitude to the risk estimate for
pre-screening cases in our study than to the estimate based on
screening-detected cases. This may be due to the heightened
awareness in the medical community in Belarus of the potential
risk of thyroid cancer among children exposed to the fallout,
especially from the heavily contaminated areas in Gomel oblast,
and widespread ultrasound screening campaigns in the first
5–10 years after the accident (Ito et al, 1997; Astakhova et al,
1998). We observed that half of pre-screening cases were among
those exposed younger than 5 years old compared with a third
among screening cases, and the mean dose of pre-screening cases
was significantly higher compared with screening cases (1.77 vs
1.08Gy) but somewhat lower compared to the Ukrainian screening
cases (2.00 Gy), supporting the possibility of early detection of
cases among those exposed at younger ages from heavily contami-
nated areas. Only 14 pre-screening cases were reported in the
Ukrainian cohort of similar size during the same period of obser-
vation and no risk analyses were reported (Tronko et al, 2006).
Several studies have investigated risk of Chornobyl-related thyroid
cancer among persons exposed as children or adolescents. Case–
control studies from the Bryansk oblast of the Russian Federation
(Davis et al, 2004; Kopecky et al, 2006) reported significantly
increased risk of thyroid cancer with no variation by gender or age of
exposure. A case–control study of thyroid cancer diagnosed in
1987–1992 in children from Belarus (Astakhova et al, 1998) found
increased risks with dose only among children exposed in Gomel
oblast, but in a later study of cases diagnosed in 1992–1998 (Cardis
et al, 2005) no differences by oblast were observed. Cardis et al
reported an OR at 1Gy of 4.9, 95% CI: 2.2–7.5 from a linear-
quadratic model over the entire dose range, with evidence of non-
linearity at doses above 1.5–2.0. Absence of individual dose
estimates and possible underascertainment of thyroid cancer cases
Table 3 Risk models and interaction terms for prevalent thyroid cancers
Modifying factor
and its value Cases EOR/Gya 95% CI P-valueb
All subjects 85 2.15 0.81–5.47
Gender
Men 36 5.89 1.36–52.72 0.08
Women 49 1.17 0.23–3.70
Age at the time of the accident, years
0–4 26 4.02 0.98–15.07 0.48
5–11 30 1.95 0.41–6.17
12–18 29 1.40 NE–4.95
Oblast of residence at the time of the accident
Minsk and other 9 2.06 o0–21.89 0.07
Gomel 76 2.51 0.99–5.98
History of diffuse goiter
No 77 1.91 0.67–4.97 o0.01
Yes 8 14.50 4.44–39.03
Diffuse goiter diagnosed at screening
No 52 1.44 0.41–4.04 o0.001
Yes 33 7.83 3.50–17.49
Urinary iodine concentration,c mg l1
0–19 10 2.40 1.91–7.55 0.30
20–49 19 1.14 NE–4.06
50–99 29 3.05 NE–7.82
100+ 27 2.17 NE–6.05
Thyroid volume enlargementd
No 71 1.74 0.56–4.68 o0.01
Yes 14 9.10 3.18–22.43
Max dimension of the tumor after thyroid pathomorphology
o10mm 44 1.35 0.22–5.26 0.30
10+ mm 41 3.40 1.00–13.11
Abbreviations: CI¼ confidence interval; EOR/Gy¼ excess odds ratio per gray;
NE¼ not estimated. Data restricted to subjects with doses o5Gy. aModel adjusted
for age at risk, gender and oblast of residence (Minsk, Gomel, Other). bP-value from
the likelihood ratio test of homogeneity across categories. cExcluding 150 subjects
with missing urinary iodine concentration. dThyroid enlargement was defined as a
thyroid volume 418ml for women and 425ml for men.
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from the Cancer Registry of Belarus could be responsible for
observed differences in risk estimates with our study (OR at
1 Gy¼ 3.68 from the linear–exponential model).
Our estimates of risk were somewhat lower than those reported
from the study of the survivors of atomic bombings in Japan where
risk at age 30 was ERR/Gy¼ 5.35 among those exposed younger
than 10 and ERR/Gy¼ 4.28 among those exposed between 10 and
19 years old (Preston et al, 2007), and much lower compared to
the estimate from the pooled analysis of risks after X-ray and
g-irradiation (ERR/Gy¼ 7.7, 95% CI: 2.1–28.7) (Ron et al, 1995).
Our CIs overlap suggesting compatibility of findings. In studies of
external irradiation of the thyroid gland, younger age at exposure
was significantly associated with increased risk and the evidence
for gender was suggestive although not uniform across studies.
Iodine deficiency is thought to increase radioiodine uptake by
the thyroid gland and to modify thyroid function after radiation
exposure (Robbins et al, 2001). Two studies reported an inverse
association between iodine deficiency, defined by low urinary
iodine excretion levels (Shakhtarin et al, 2003) or levels of stable
iodine in soil in areas of residence at the time of accident (Cardis
et al, 2005), and increased risk of radiation-associated thyroid
cancer. In the parallel Ukrainian study, place of residence and
current iodine excretion did not modify the risk of thyroid cancer
(Tronko et al, 2006) or the risk of benign follicular adenoma
(Zablotska et al, 2008). The areas of the northern Ukraine where
the study was conducted have more severe iodine insufficiency
than the study areas in Belarus, where at the time of screening two-
thirds of study participants were iodine deficient with urine levels
o100 mg l1 (Table 1). We used four proxy indicators to describe
past iodine deficiency and observed that history of diffuse goiter,
and diffuse goiter and thyroid volume enlargement diagnosed
during screening were significant modifiers of cancer risk.
Study participants exposed in Gomel oblast had higher risks
compared to subjects from other oblasts (P¼ 0.07) and the
difference in risk estimates was even more pronounced and
significant in the combined analysis of pre-screening and prevalent
cases (P¼ 0.04). This could be an indication of more severe past
iodine deficiency in Gomel oblast. Although the prevalence of
goiter at the time of screening in our study was comparable across
oblasts, several reports (Kholodova and Fedorova, 1992; Gerasi-
mov, 1993; Gembicki et al, 1997) have suggested that iodine
deficiency in Gomel oblast around the time of the accident was
high and described concerted governmental efforts of iodine
supplementation in Gomel 5–10 years after the accident (VanMid-
dlesworth, 2002).
We did not observe any differences in risk by the size of
tumour. To evaluate the effect of referral of smaller nodules
sonographically suspicious for malignancy for biopsy, we
analysed size of nodule referred for FNA among non-incidental
cases (5–10 vs X10mm) and estimated an EOR/Gy of 3.43
(95% CI: not estimated to 464) for the group of smaller
nodules (N¼ 20 cases) and 1.85 (95% CI: 0.79–4.01) for the larger
nodules (N¼ 53, P40.50; not shown). The clinical importance of
small screening-detected cancers is not well understood and we
could not evaluate it in this study based on the first round of
screening.
Our findings indicate that in a cohort of children and
adolescents from Belarus exposed to the fallout from the
Chornobyl accident, thyroid cancer is associated with exposure
to 131I. Future analyses of incident thyroid cancers identified
during additional two screening cycles (2001–2007) should shed
light on the clinical importance of screening-detected tumours and
age at exposure and time trends effects.
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Table 4 Models of EOR/Gy and interaction terms for pre-screening and a combined set of pre-screening and prevalent thyroid cancers
Pre-screening cases Pre-screening and prevalent cases
Modifying factor and
its values Cases EOR/Gya 95% CI P-valueb Cases EOR/Gya 95% CI P-valueb
All subjects 48 8.18 2.11–72.71 133 3.16 1.49–6.95
Gender
Men 26 2.68 NE–74.59 0.88 62 6.27 1.96–30.44 0.13
Women 22 9.09 1.55–103.30 71 2.06 0.75–5.31
Age at exposure, years
0–4 23 4.98 0.91–43.94 0.32 49 2.82 1.04–7.27 0.92
5–7 12 10.44 2.56–76.99 24 3.33 1.14–8.37
8–18 13 12.24 1.88–109.40 60 3.43 1.23–8.92
Oblast of residence at the time of the accident
Minsk and other 6 10.09 2.70–63.26 0.15 15 1.00 NE–4.19 0.04
Gomel 42 3.41 NE–35.40 118 3.93 1.85–8.65
Abbreviations: CI¼ confidence interval; EOR/Gy¼ excess odds ratio per gray; NE¼ not estimated. Data restricted to subjects with doseso5Gy. aModel adjusted for age at risk,
gender and oblast of residence (Minsk, Gomel, Other). bP-value from the likelihood ratio test of homogeneity across categories.
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